Rachel A Freedman1, Elena M Kouri2, Dee W West3, Shoshana Rosenberg4, Ann H Partridge4, Joyce Lii5, Nancy L Keating6. 1. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. Electronic address: rafreedman@partners.org. 2. Harvard Medical School, Department of Health Care Policy, Boston, MA. 3. Cancer Registry of Greater California, Public Health Institute, Sacramento, CA. 4. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. 5. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA. 6. Harvard Medical School, Department of Health Care Policy, Boston, MA; Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA.
Abstract
BACKGROUND: The reasons for increasing rates of bilateral mastectomy for unilateral breast cancer are incompletely understood, and associations of disease stage with bilateral surgery have been inconsistent. We examined associations of clinical and sociodemographic factors, including stage, with surgery type and reconstruction receipt among women with breast cancer. PATIENTS AND METHODS: We surveyed a diverse population-based sample of women from Northern California cancer registries with stage 0 to III breast cancer diagnosed during 2010-2011 (participation rate, 68.5%). Using multinomial logistic regression, we examined factors associated with bilateral and unilateral mastectomy (vs. breast-conserving surgery), adjusting for tumor and sociodemographic characteristics. In a second model, we examined factors associated with reconstruction for mastectomy-treated patients. RESULTS: Among 487 participants, 58% had breast-conserving surgery, 32% had unilateral mastectomy, and 10% underwent bilateral mastectomy. In adjusted analyses, women with stage III (vs. stage 0) cancers had higher odds of bilateral mastectomy (odds ratio [OR], 8.28; 95% confidence interval, 2.32-29.50); women with stage II and III (vs. stage 0) disease had higher odds of unilateral mastectomy. Higher (vs. lower) income was also associated with bilateral mastectomy, while age ≥ 60 years (vs. < 50 years) was associated with lower odds of bilateral surgery. Among mastectomy-treated patients (n = 206), bilateral mastectomy, unmarried status, and higher education and income were all associated with reconstruction (P < .05). CONCLUSION: In this population-based cohort, women with the greatest risk of distant recurrence were most likely to undergo bilateral mastectomy despite a lack of clear medical benefit, raising concern for overtreatment. Our findings highlight the need for interventions to assure women are making informed surgical decisions.
BACKGROUND: The reasons for increasing rates of bilateral mastectomy for unilateral breast cancer are incompletely understood, and associations of disease stage with bilateral surgery have been inconsistent. We examined associations of clinical and sociodemographic factors, including stage, with surgery type and reconstruction receipt among women with breast cancer. PATIENTS AND METHODS: We surveyed a diverse population-based sample of women from Northern California cancer registries with stage 0 to III breast cancer diagnosed during 2010-2011 (participation rate, 68.5%). Using multinomial logistic regression, we examined factors associated with bilateral and unilateral mastectomy (vs. breast-conserving surgery), adjusting for tumor and sociodemographic characteristics. In a second model, we examined factors associated with reconstruction for mastectomy-treated patients. RESULTS: Among 487 participants, 58% had breast-conserving surgery, 32% had unilateral mastectomy, and 10% underwent bilateral mastectomy. In adjusted analyses, women with stage III (vs. stage 0) cancers had higher odds of bilateral mastectomy (odds ratio [OR], 8.28; 95% confidence interval, 2.32-29.50); women with stage II and III (vs. stage 0) disease had higher odds of unilateral mastectomy. Higher (vs. lower) income was also associated with bilateral mastectomy, while age ≥ 60 years (vs. < 50 years) was associated with lower odds of bilateral surgery. Among mastectomy-treated patients (n = 206), bilateral mastectomy, unmarried status, and higher education and income were all associated with reconstruction (P < .05). CONCLUSION: In this population-based cohort, women with the greatest risk of distant recurrence were most likely to undergo bilateral mastectomy despite a lack of clear medical benefit, raising concern for overtreatment. Our findings highlight the need for interventions to assure women are making informed surgical decisions.
Authors: Caprice K Christian; Joyce Niland; Stephen B Edge; Rebecca A Ottesen; Melissa E Hughes; Richard Theriault; John Wilson; Charles A Hergrueter; Jane C Weeks Journal: Ann Surg Date: 2006-02 Impact factor: 12.969
Authors: Marlene H Frost; Jeffrey M Slezak; Nho V Tran; Constance I Williams; Joanne L Johnson; John E Woods; Paul M Petty; John H Donohue; Clive S Grant; Jeff A Sloan; Thomas A Sellers; Lynn C Hartmann Journal: J Clin Oncol Date: 2005-10-03 Impact factor: 44.544
Authors: Awais Ashfaq; Lee J McGhan; Barbara A Pockaj; Richard J Gray; Sanjay P Bagaria; Sarah A McLaughlin; William J Casey; Alanna M Rebecca; Peter Kreymerman; Nabil Wasif Journal: Ann Surg Oncol Date: 2014-04-23 Impact factor: 5.344
Authors: Lisa D Chew; Joan M Griffin; Melissa R Partin; Siamak Noorbaloochi; Joseph P Grill; Annamay Snyder; Katharine A Bradley; Sean M Nugent; Alisha D Baines; Michelle Vanryn Journal: J Gen Intern Med Date: 2008-03-12 Impact factor: 5.128
Authors: Danny Yakoub; Eli Avisar; Tulay Koru-Sengul; Feng Miao; Stacey L Tannenbaum; Margaret M Byrne; Frederick Moffat; Alan Livingstone; Dido Franceschi Journal: Breast Cancer (Dove Med Press) Date: 2015-01-07
Authors: Erin M Taylor; Edwin G Wilkins; Andrea L Pusic; Ji Qi; Hyungjin Myra Kim; Jennifer B Hamill; Gretchen E Guldbrandsen; Yoon S Chun Journal: Plast Reconstr Surg Date: 2019-06 Impact factor: 4.730
Authors: Chelsea Anderson; Jessica Y Islam; M Elizabeth Hodgson; Susan A Sabatino; Juan L Rodriguez; Clara N Lee; Dale P Sandler; Hazel B Nichols Journal: Ann Surg Oncol Date: 2017-01-05 Impact factor: 5.344
Authors: Mya L Roberson; Hazel B Nichols; Andrew F Olshan; Stephanie B Wheeler; Katherine E Reeder-Hayes; Whitney R Robinson Journal: Breast Cancer Res Treat Date: 2022-03-14 Impact factor: 4.624
Authors: Christopher D Lopez; Rachel Bluebond-Langner; Carrie A Houssock; Sheri S Slezak; Emily Bellavance Journal: Front Oncol Date: 2019-01-09 Impact factor: 6.244